These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 9316855)
1. Metabolite involvement in bromocriptine-induced prolactin inhibition in rats. Valente D; Delaforge M; Urien S; Guivarc'h D; Vienet R; Grognet JM; Ezan E J Pharmacol Exp Ther; 1997 Sep; 282(3):1418-24. PubMed ID: 9316855 [TBL] [Abstract][Full Text] [Related]
2. Dopamine agonist activities of pergolide, its metabolites, and bromocriptine as measured by prolactin inhibition, compulsive turning, and stereotypic behavior. Clemens JA; Okimura T; Smalstig EB Arzneimittelforschung; 1993 Mar; 43(3):281-6. PubMed ID: 8489554 [TBL] [Abstract][Full Text] [Related]
3. Bromocriptine modulates P-glycoprotein function. Orlowski S; Valente D; Garrigos M; Ezan E Biochem Biophys Res Commun; 1998 Mar; 244(2):481-8. PubMed ID: 9514944 [TBL] [Abstract][Full Text] [Related]
4. Effect of repeated L-DOPA, bromocriptine, or lisuride administration on preproenkephalin-A and preproenkephalin-B mRNA levels in the striatum of the 6-hydroxydopamine-lesioned rat. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1999 Feb; 155(2):204-20. PubMed ID: 10072296 [TBL] [Abstract][Full Text] [Related]
5. Serotonin antagonist-induced lowering of prolactin secretion does not affect the pattern of pulsatile secretion of follicle-stimulating hormone and luteinizing hormone in the bitch. Beijerink NJ; Kooistra HS; Dieleman SJ; Okkens AC Reproduction; 2004 Aug; 128(2):181-8. PubMed ID: 15280557 [TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic and pharmacodynamic analyses, based on dopamine D2-receptor occupancy of bromocriptine, of bromocriptine-induced contralateral rotations in unilaterally 6-OHDA-lesioned rats. Atsumi M; Kawakami J; Sugiyama E; Kotaki H; Sawada Y; Sato H; Yamada Y; Iga T Synapse; 2003 Nov; 50(2):110-6. PubMed ID: 12923813 [TBL] [Abstract][Full Text] [Related]
7. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice. Beland FA Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702 [TBL] [Abstract][Full Text] [Related]
8. Central bromocriptine-induced tachycardia is reversed to bradycardia in conscious, deoxycorticosterone acetate-salt hypertensive rats. Lahlou S Pharmacol Toxicol; 2001 May; 88(5):238-43. PubMed ID: 11393583 [TBL] [Abstract][Full Text] [Related]
9. Differential effects of talipexole and bromocriptine on serotonin release from rat intestinal tissues--an in vitro study of the emetic response of antiparkinsonian dopamine agonists. Minami M; Kohno Y; Endo T; Nemoto M; Ogawa T; Ihira E; Hamaue N; Hirafuji M Res Commun Mol Pathol Pharmacol; 1999; 104(1):3-12. PubMed ID: 10604273 [TBL] [Abstract][Full Text] [Related]
10. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
11. Metabolites of an antipsychotic chiral pyrroloisoquinoline and their effect on prolactin secretion in the rat. Kolis SJ; Williams TH; Mowles TF; Burghardt B; Toome V; Schwartz MA J Pharmacol Exp Ther; 1983 Dec; 227(3):652-7. PubMed ID: 6140308 [TBL] [Abstract][Full Text] [Related]
12. Blood-brain barrier permeability and in vivo activity of partial agonists of benzodiazepine receptor: a study of L-663,581 and its metabolites in rats. Lin JH; Chen IW; Lin TH J Pharmacol Exp Ther; 1994 Dec; 271(3):1197-202. PubMed ID: 7996426 [TBL] [Abstract][Full Text] [Related]
13. Characterization of enhanced behavioral responses to L-DOPA following repeated administration in the 6-hydroxydopamine-lesioned rat model of Parkinson's disease. Henry B; Crossman AR; Brotchie JM Exp Neurol; 1998 Jun; 151(2):334-42. PubMed ID: 9628768 [TBL] [Abstract][Full Text] [Related]
14. Endogenous prolactin modulated the calcium absorption in the jejunum of suckling rats. Amnattanakul S; Charoenphandhu N; Limlomwongse L; Krishnamra N Can J Physiol Pharmacol; 2005 Jul; 83(7):595-604. PubMed ID: 16091785 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of atorvastatin and its hydroxy metabolites in rats and the effects of concomitant rifampicin single doses: relevance of first-pass effect from hepatic uptake transporters, and intestinal and hepatic metabolism. Lau YY; Okochi H; Huang Y; Benet LZ Drug Metab Dispos; 2006 Jul; 34(7):1175-81. PubMed ID: 16624870 [TBL] [Abstract][Full Text] [Related]
16. Effects of long-term pretreatment with isoproterenol on bromocriptine-induced tachycardia in conscious rats. Lahlou S; Lima GC; Leão-Filho CS; Duarte GP Can J Physiol Pharmacol; 2000 Mar; 78(3):260-5. PubMed ID: 10721819 [TBL] [Abstract][Full Text] [Related]
17. Dopamine agonistic effects as opposed to prolactin concentrations in plasma as the influencing factor on the duration of anoestrus in bitches. Okkens AC; Kooistra HS; Dieleman SJ; Bevers MM J Reprod Fertil Suppl; 1997; 51():55-8. PubMed ID: 9404271 [TBL] [Abstract][Full Text] [Related]
18. Sumanirole, a highly dopamine D2-selective receptor agonist: in vitro and in vivo pharmacological characterization and efficacy in animal models of Parkinson's disease. McCall RB; Lookingland KJ; Bédard PJ; Huff RM J Pharmacol Exp Ther; 2005 Sep; 314(3):1248-56. PubMed ID: 15980060 [TBL] [Abstract][Full Text] [Related]
19. Anoestrus in the dog: a fascinating story. Okkens AC; Kooistra HS Reprod Domest Anim; 2006 Aug; 41(4):291-6. PubMed ID: 16869884 [TBL] [Abstract][Full Text] [Related]
20. Microdialysis study of bromocriptine and its metabolites in rat pituitary and striatum. Granveau-Renouf S; Valente D; Durocher A; Grognet JM; Ezan E Eur J Drug Metab Pharmacokinet; 2000; 25(2):79-84. PubMed ID: 11112086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]